About Dyadic
Dyadic is a company based in Jupiter (United States) founded in 1979.. The company has 6 employees as of December 31, 2024. Dyadic offers products and services including C1 Platform, Dapibus™ Platform, and Vaccines and Antibodies. Dyadic operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Jupiter, United States
- Employees 6 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dyadic International, Inc.
-
Annual Revenue
$3.5 M20.58as on Dec 31, 2024
-
Net Profit
$-5.81 M14.51as on Dec 31, 2024
-
EBITDA
$-5.88 M28.24as on Dec 31, 2024
-
Latest Funding Round
-
Investors
European Commission
& 3 more
-
Employee Count
6
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Dyadic
Dyadic is a publicly listed company on the NASDAQ with ticker symbol DYAI in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Dyadic
Dyadic offers a comprehensive portfolio of products and services, including C1 Platform, Dapibus™ Platform, and Vaccines and Antibodies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for producing industrial enzymes and therapeutic proteins efficiently
System for low-cost proteins in food, nutrition, and biopharmaceutical applications
Recombinant products for human and animal health treatments
Unlock access to complete
Unlock access to complete
Leadership Team
9 people
Finance and Accounting
2 people
Sales and Marketing
1 people
Staff Team
1 people
Unlock access to complete
Funding Insights of Dyadic
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(05 Nov 2004)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2015 | Amount | Grant - Dyadic | Valuation |
investors |
|
| Mar, 2015 | Amount | Post-IPO - Dyadic | Valuation |
investors |
|
| Oct, 2011 | Amount | Post-IPO - Dyadic | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dyadic
Dyadic has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, Brean Capital and Crestview Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focusing on partnerships, business strategy, and value addition through experience.
|
Founded Year | Domain | Location | |
|
Institution of the European Union responsible for upholding the EU treaties
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dyadic
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dyadic
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dyadic Comparisons
Competitors of Dyadic
Dyadic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dyadic
Frequently Asked Questions about Dyadic
When was Dyadic founded?
Dyadic was founded in 1979 and raised its 1st funding round 25 years after it was founded.
Where is Dyadic located?
Dyadic is headquartered in Jupiter, United States. It is registered at Jupiter, Florida, United States.
How many employees does Dyadic have?
As of Dec 31, 2024, the latest employee count at Dyadic is 6.
What is the annual revenue of Dyadic?
Annual revenue of Dyadic is $3.5M as on Dec 31, 2024.
What does Dyadic do?
Dyadic was founded in 1979 and is based in Jupiter, United States. Microbial platforms are developed for industrial and therapeutic uses within the biotechnology sector. The proprietary C1 expression system is refined and applied to support protein production for vaccines and pharmaceuticals. Operations emphasize scalable solutions for bringing biologics to market, with activities centered on expression technology advancements.
Who are the top competitors of Dyadic?
Dyadic's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Dyadic offer?
Dyadic offers C1 Platform, Dapibus™ Platform, and Vaccines and Antibodies.
Is Dyadic publicly traded?
Yes, Dyadic is publicly traded on NASDAQ under the ticker symbol DYAI.
Who are Dyadic's investors?
Dyadic has 4 investors. Key investors include European Commission, Brean Capital, Crestview Partners, and Mercantile Capital.
What is Dyadic's ticker symbol?
The ticker symbol of Dyadic is DYAI on NASDAQ.